The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men

Kidney International

Volumn 67, Issue 6, 2005, Pages 2376-2382

  Rule, Andrew D ^b   Jacobson, Debra J ^b   Roberts, Rosebud O ^b   Girman, Cynthia J ^b   McGree, Michaela E ^b   Lieber, Michael M ^b   Jacobsen, Steven J ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Bladder neck obstruction; Chronic kidney failure; Creatinine; Prostatic hyperplasia

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; COMMUNITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; EUROPEAN AMERICAN; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK FACTOR; UNITED STATES; URINARY TRACT INFECTION; URINE FLOW RATE; URINE RETENTION; URINE VOLUME; BLADDER OBSTRUCTION; CHRONIC DISEASE; KIDNEY DISEASE; MIDDLE AGED; RISK;

ADULT; AGED; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PROSTATIC HYPERPLASIA; RISK FACTORS; URINARY BLADDER NECK OBSTRUCTION;

EID: 23044480568     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00344.x     Document Type: Article

References (32)

1. CORESH J, ASTOR BC, GREENE T, et al Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1-12, 2003
2. HAROUN MK, BERNARD GJ, HUFFMAN SC, et al Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14:2934-2941, 2003
3. Fox CS, LARSON MG, LEIP EP, et al: Predictors of new-onset kidney disease in a community-based population. JAMA 291:844-850, 2004
4. CHEN J, MUNTNER P, HAMM LL, et al The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167-174, 2004
5. NATIONAL KIDNEY FOUNDATION, KIDNEY DISEASE OUTCOME QUALITY INITIATIVE ADVISORY BOARD: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39(2 Suppl 2):S1-246, 2002
6. GEORGE NJ, O'REILLY PH, BARNARD RJ, BLACKLOCK NJ: High pressure chronic retention. Br Med J (Clin Res Ed) 286:1780-1783, 1983
7. STYLES RA, NEAL DE, GRIFUTHS CJ, RAMSDEN PD: Long-term monitoring of bladder pressure in chronic retention of urine: The relationship between detrusor activity and upper tract dilatation. J Urol 140:330-334, 1988
8. COMITER CV, SULLIVAN MP, SCHACTERLE RS, et al: Urodynamic risk factors for renal dysfunction in men with obstructive and nonobstructive voiding dysfunction. J Urol 158:181-185, 1997
9. EMBERTON M, ANDRIOLE GL, DE LA ROSETTE J, et al: Benign prostatic hyperplasia: A progressive disease of aging men. Urology 61:267-273, 2003
10. JACOBSEN SJ, GIRMAN CJ, GUESS HA, et al: New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States. Arch Intern Med 155:477-481, 1995
11. AUA PRACTICE GUIDELINES COMMITTEE: AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 170:530-547, 2003
12. DE LA ROSETTE JJ, ALIVIZATOS G, MADERSBACHER S, et al: EAU Guidelines on benign prostatic hyperplasia (BPH). Eur Urol 40:256-263, 2001
13. JACOBSEN SJ, GIRMAN CJ, GUESS HA, et al: Natural history of prostatism: Factors associated with discordance between frequency and bother of urinary symptoms. Urology 42:663-671, 1993
14. MELTON LJ III: History of the Rochester Epidemiology Project. Mayo Clin Proc 71:266-274,1996
15. PANSER LA, CHUTE CG, GUESS HA, et al: The natural history of prostatism: The effects of non-response bias. Int J Epidemiol 23:1198-1205, 1994
16. BARRY MJ, FOWLER FJJ, O'LEARY MP, et al: The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 148:1549-1557, 1992
17. TERRIS MK, STAMEY TA: Determination of prostate volume by transrectal ultrasound. J Urol 145:984-987, 1991
18. ROEHRBORN CG, BOYLE P, GOULD AL, WALDSTREICHER J: Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53:581-589, 1999
19. SCHACTERLE RS, SULLIVAN MP, YALLA SV: Combinations of maximum urinary flow rate and American Urological Association symptom index that are more specific for identifying obstructive and non-obstructive prostatism. Neurourol Urodyn 15:459-470, 1996
20. LEVEY AS, CORESH J, BALK E, et al: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139:137-147, 2003
21. RULE AD, LARSON TS, BERGSTRALH EJ, et al: Using serum creatinine to estimate glomerular filtration rate: Accuracy in good healthy and in chronic kidney disease. Ann Intern Med 141:929-937, 2004
22. ROEHRBORN CG, McCoNNELL JD, SALTZMAN B, et al: Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. Eur Urol 42:1-6, 2002
23. HUNTER DJ, BERRA-UNAMUNO A, MARTIN-GORDO A: Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J Urol 155:1965-1970, 1996
24. HILL AM, PHILPOTT N, KAY JD, et al: Prevalence and outcome of renal impairment at prostatectomy. Br J Urol 71:464-468, 1993
25. JONES DA, GILPIN SA, HOLDEN D, et al: Relationship between bladder morphology and long-term outcome of treatment in patients with high pressure chronic retention of urine. Br J Urol 67:280-285, 1991
26. NISSENKORN I, SAVION M, SERVADIO C: Renal and bladder function recovery after prostatectomy in patients with a chronic residual urine of above 1,000 mL. Eur Urol 14:434-436, 1988
27. GHOSE RR: Prolonged recovery of renal function after prostatectomy for prostatic outflow obstruction. BMJ 300:1376-1377, 1990
28. COHEN EP, SOBRERO M, ROXE DM, LEVIN ML: Reversibility of long-standing urinary tract obstruction requiring long-term dialysis. Arch Intern Med 152:177-179, 1992
29. McCoNNELL J, ROEHRBORN CG, BAUTISTA OM, et al: The long-term effect of doxazosin, fmasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349:2387-2398, 2003
30. FLANIGAN RC, REDA DJ, WASSON JH, et al: Five-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: A Department of Veterans Affairs cooperative study. J Urol 160:12-16, 1998
31. GERBER GS, GOLDUSCHER ER, KARRISON TG, BALES GT: Serum creatinine measurements in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 49:697-702, 1997
32. SUTARIA PM, STASKIN DR: Hydronephrosis and renal deterioration in the elderly due to abnormalities of the lower urinary tract and ureterovesical junction, Int Urol Nephrol 32:119-126, 2000